Status:
COMPLETED
Study "HEMORROIDAL SURGERY AND Chronic Inflammatory Bowel Disease"
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Hemorrhoids
Chronic Inflammatory Bowel Disease
Eligibility:
All Genders
18+ years
Brief Summary
Hemorrhoidal surgery is considered potentially harmful in patients with chronic inflammatory bowel disease (IBD). Patients with Crohn's disease may have ano-perineal involvement during the course of t...
Eligibility Criteria
Inclusion
- Patient whose age is ≥ 18 years
- Patient with IBD (Crohn's or UC) with a diagnosis prior to hemorrhoidal surgery
- Patient operated on for hemorrhoidal surgery performed between November 1, 2013 and July 7, 2020 in our center
- French-speaking patient
Exclusion
- Patient with severe inflammatory disease
- Patient with ano-perineal involvement of Crohn's disease
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient under legal protection
- Patient objecting to the use of their data for this research
Key Trial Info
Start Date :
December 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 26 2023
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04692194
Start Date
December 28 2020
End Date
April 26 2023
Last Update
April 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, Groupe Hospitalier Paris Saint-Joseph, France, 75014